Loss of imprinting and abnormal expression of the insulin-like growth factor 2 gene in gastric cancer

A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations

(2010) Sreenath V. Sharma et al.   CELL

Targeting the Insulin-like Growth Factor Receptor-1R Pathway for Cancer Therapy

(2010) J. Zha et al.   CLINICAL CANCER RESEARCH

Temporal stability and age-related prevalence of loss of imprinting of the insulin-like growth factor-2 gene

(2010) Marcia Cruz-Correa et al.   Epigenetics

Effect of type 1 insulin-like growth factor receptor targeted therapy on chemotherapy in human cancer and the mechanisms involved

(2010) Alyse Hopkins et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Loss of imprinting of the insulin-like growth factor II (IGF2) gene in esophageal normal and adenocarcinoma tissues

(2009) R. Zhao et al.   CARCINOGENESIS

Loss of imprinting of insulin-like growth factor 2 is associated with increased risk of lymph node metastasis and gastric corpus cancer

(2009) Yang Lu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Impact of Insulin-Like Growth Factor Type 1 Receptor, Epidermal Growth Factor Receptor, and HER2 Expressions on Outcomes of Patients with Gastric Cancer

(2008) J. Matsubara et al.   CLINICAL CANCER RESEARCH

Epigenetic Aberrations and Targeted Epigenetic Therapy of Esophageal Cancer

(2008) Ronghua Zhao et al.   CURRENT CANCER DRUG TARGETS